Rayence Co

Rayence Co Operating Cash Flow

The Operating Cash Flow of Rayence Co (228850.KQ) as of Oct 22, 2026 is 9.21 B KRW. In the previous year, Operating Cash Flow was 24.84 B KRW — a change of -62.93% (lower).

Operating Cash Flow

9.21 BKRW

YoY

-62.93%

Last updated:

Operating Cash Flow of Rayence Co is 2025 9.21 B KRW. Operating Cash Flow of Rayence Co was 2024 24.84 B KRW. It decreases by -62.93% lower compared to the previous year.

The Rayence Co Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2018
14.70 B KRW
Jan 1, 2019
9.45 B KRW
Jan 1, 2020
23.25 B KRW
Jan 1, 2021
20.94 B KRW
Jan 1, 2022
16.61 B KRW
Jan 1, 2023
25.82 B KRW
Jan 1, 2024
24.84 B KRW
Jan 1, 2025
9.21 B KRW
The Rayence Co Operating Cash Flow history
YEAROperating Cash FlowYoY
9.21 BKRW-62.93%
24.84 BKRW-3.80%
25.82 BKRW+55.47%
16.61 BKRW-20.69%
20.94 BKRW-9.96%
23.25 BKRW+146.00%
9.45 BKRW-35.70%
14.70 BKRW-28.69%
20.62 BKRW+146.40%
8.37 BKRW-10.33%
9.33 BKRW+31.95%
7.07 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rayence Co Stock analysis

What does Rayence Co do? Rayence Co., Ltd. generates revenue through the manufacturing and sale of x-ray detectors, including TFT and CMOS detectors under brand names such as 1012WCA, 17SCC/SGC, 1215CF, 1501CF, and 0712CF. The company also produces intra oral sensors branded as Ez1.0 and Ez1.5, along with mammography machines under the 1724CM and 2434CM series. These products are distributed to both domestic and international markets, serving healthcare providers and medical facilities that require diagnostic imaging equipment. The primary customers for Rayence's detectors and sensors are hospitals, clinics, and medical imaging centers seeking advanced x-ray technology. The firm's product portfolio targets the medical imaging segment, focusing on applications such as dental diagnostics with intra oral sensors and radiological imaging with mammography machines. Revenue streams are derived from direct sales of these branded products to healthcare institutions across multiple regions. Rayence's business model centers on selling specialized medical imaging equipment under its own brand names, with no mention of third-party partnerships or additional services. The company's revenue is directly tied to the purchase of its branded x-ray detectors, intra oral sensors, and mammography machines by healthcare providers who require high-quality diagnostic tools for patient care. Rayence Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rayence Co stock

Operating Cash Flow of Rayence Co is 9.21 B KRW in 2025.

Operating Cash Flow of Rayence Co changed from 24.84 B KRW to 9.21 B KRW, representing a -62.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Rayence Co since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Rayence Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Rayence Co

All Key Metrics — Rayence Co